Everett E. Vokes, MD | Authors

Articles

Dr. Vokes Discusses PARP Inhibitors in Lung Cancer

October 12, 2017

Everett E. Vokes, MD, John E. Ultmann Professor of Medicine and Radiation Oncology, physician-in-chief, University of Chicago Medicine, and biological sciences chair, department of medicine, discusses PARP inhibitors for the treatment of lung cancer.

The Current Role of Checkpoint Inhibitors in Head and Neck Cancer

October 10, 2017

Everett E. Vokes, MD, John E. Ultmann Professor of Medicine and Radiation Oncology, Physician-in-Chief, University of Chicago Medicine and Biological Sciences, Chair, Department of Medicine, discusses the current role of checkpoint inhibitors for the treatment of head and neck cancer during the ESMO 2017 Congress.